• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>ResMed

ResMed

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. ResMed Provides Update on Phase III SERVE-HF Study of Adaptive Servo-Ventilation (ASV) Therapy In Central Sleep Apnea and Chronic Heart Failure

    ResMed Provides Update on Phase III SERVE-HF Study of Adaptive Servo-Ventilation (ASV) Therapy In Central Sleep Apnea and Chronic Heart Failure

  2. Age 70 1/2: Think Through Your RMD Choices

    Buying a qualified longevity annuity and tactically timing the first RMD could reduce the tax hit.

  3. Age 70 1/2: Think Through Your RMD Choices

    Buying a qualified longevity annuity and tactically timing the first RMD could reduce the tax hit.

  4. 6 Mistakes to Avoid With Taxable Accounts

    Taxable accounts can play a key role for investors, so long as they are careful about what investments they put in and how they sequence withdrawals.

  5. Australia stocks suffer hit from miners, health shares

    Australia stocks suffer hit from miners, health shares

  6. 5 RMD Pitfalls to Avoid

    Make sure your RMD decisions add up from an investment and tax standpoint.

  7. Lincoln Financial Offers QLAC Status on Deferred Income Annuity Providing Advisors Additional Tool To Address Client Longevity Income Needs

    Lincoln Financial Offers QLAC Status on Deferred Income Annuity Providing Advisors Additional Tool To Address Client Longevity Income Needs

  8. RMD Surprises!

    Little-known  RMD issues do pop up every once and awhile.

  9. Global Sleep Apnea Diagnostic and Therapeutic Devices Market to Be Propelled by Greater Technological Advancements: Transparency Market Research

    Global Sleep Apnea Diagnostic and Therapeutic Devices Market to Be Propelled by Greater Technological Advancements: Transparency Market Research

  10. RMD Conundrums

    Natalie Choate answers reader questions about calculating multiple beneficiary and 'much younger spouse' RMDs.

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.